Call Us: +1 914.613.3002
Wakabayashi Fund LLC., a private equity firm with offices in Tokyo, Japan and New York, NY, provides corporate capitalization and institutional investor relations consulting services. read more
Through extensive operating and international venture capital investing experience, we have access to a network of contacts in professional organizations and financial institutions that are most useful to the client. read more
We have developed a specialty in associating with such owners and managers and helping them resolve the conflict between their personal financial goals and the needs of their business. read more
LATEST WORKS
Our entire premise is based on established relationships and our reputation for consistently delivering relevant information and insight. Here, you will find the unsurpassed quality of our work and presentation for our clients.
OUR FOCUS
There are a substantial number of small-cap market companies in the United States as well as off-shore. Many were founded several decades ago and now the owners or their children want to liquefy their holdings.
FINANCING TYPES
Investments take a variety of forms ranging from straight equity, hybrid, or debt. All of our principal and agency transactions involve a significant degree of equity participation, which is commensurate with the risk and is essential to achieving our objective of capital appreciation. Cryptocurrency investment is the most popular among all other types of investments since it allows investors to earn significant profits without having to do a lot of research. This is made feasible by the emergence of auto-trading softwares such as Cryptosoft Robot, which automates traders manual work and performs analysis and trade placement on their behalf.
ABOUT US
Wakabayashi Fund LLC., a private equity fund with offices in Tokyo, Japan and New York, NY, provides corporate capitalization and institutional investor relations consulting services. Wakabayashi Fund may invest on a principal basis and acts in an agency capacity to procure capital for both profitable and emerging small-cap companies, identifying institutional funding sources for its clients and further develops the investor relations activities.
